NCT00390975View on ClinicalTrials.gov

Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis

PHASE4TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
GastroparesisDiabetes
Interventions
DRUG

Tegaserod

Trial Locations (3)

40292

The University of Louisville, Louisville

66160

The University of Kansas Medical Center, Kansas City

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY